CXCL8 and intrahepatic cholangiocarcinoma: This indicated that the expression of ALDH1A1 is crucial for IL-8 to promote ICC progression, and inhibiting IL-8/CXCR2 can also inhibit the tumor-promoting effect of ALDH1A1.